Stockreport

BRIEF-Heat Biologics - Interim Results From Phase 2 Study Investigating HS-110 In Combination With Anti-PD-1 [Reuters]

Heat Biologics, Inc.  (HTBX) 
Last heat biologics, inc. earnings: 8/14 07:00 am Check Earnings Report
PDF BRIEF-Heat Biologics - Interim Results From Phase 2 Study Investigating HS-110 In Combination With Anti-PD-1 | Reuters Reuters Staff 1 Min Read Feb 28 (Reuters) - Bristo [Read more]